Waldencast SPAC
We test and demonstrate our transformative
research-backed results in studies and visuals
Case study: Nu-Derm®
Baseline
93%
of patients rated their
test treatment as
more effective than
other medications²
Week 4
95%
of patients were
satisfied with the
overall effectiveness
of the test treatment²
5
4
3
2
1
0
Skin condition treated:
Melasma¹
Median grade for melasma severity
4
8
12
Week
16
20
Source: "Treating Melasma With a 4% Hydroquinone Skin Care System Plus Tretinoin Cream: Results From 3 Studies in A Variety Patient Types"; Authors: Michael Gold, MD; Suzanne Bruce, MD; Pearl Grimes, MD; Barry DiBernardo, MD; JoAnne Watson, DPM; Marta
Rendon, MD, FAAD & Chere Lucas-Anthony, MD, FAAD; Number of subjects who completed the study: 61; 1 A condition in which brown patches appear on the face. **P≤.01, ***P<.001 versus baseline; 2 Data as of week 24.
Note: For Important Safety Information, please see slide 53; The photos have not been retouched, results may vary.
24
Moderate
Moderate
Mild
Mild
Minimal
/ trace
None
4% hydroquinone skin care system + 0.025% tretinoin cream
4% hydroquinone skin care system + 0.05% tretinoin cream
▲ 4% hydroquinone skin care system + 0.1% tretinoin cream
37View entire presentation